La amplia base de datos clnicos facilita la interpretacin de los resultados experimentales
The longest we sat through a drawdown was on STVN which I probably got too attached to the story on
If standard doses are not tolerated, clinically appropriate alternatives might include slower titration (still within SmPC guidelines), switching to a different GLP-1 receptor agonist, considering other medication classes, enhancing diet/lifestyle support, or specialist review
Taibbi G, Cromwell RL, Kapoor KG, Godley BF, Vizzeri G
So whats the point
Therefore, at steady state, the variability in total and within-subject variability in exposure is reduced compared with after a single dose